Martin Kåberg

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF HEPATOLOGY. 2024;80(2):232-242

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.

Polaris Observatory Collaborators
Article: SUBSTANCE USE & MISUSE. 2023;58(12):1473-1482

Legal Minors Who Inject: Differences in Socio-Demographics and Treatment Needs Compared to Adults in a Swedish National Sample of People with Injecting Drug Use.

Turner R; Barrett D; Petersson F; Kåberg M
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(10):879-907

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Polaris Observatory Collaborators
Article: BMC PUBLIC HEALTH. 2023;23(1):1608

A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.

Metrebian N; Carter B; Eide D; McDonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kåberg M; Kelleher M; Smith J; Thiesen H; Strang J
Article: JOURNAL OF HEPATOLOGY. 2023;79(2):576-580

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.

Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen P-J; Cheon M-E; Chuang W-L; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg A-S; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu Y-C; Hu C-C; Huang J-F; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao J-H; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee M-H; Lim Y-S; Marotta PJ; Navas M-C; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang H-I; Yu M-L; Zuckerman E; Polaris Observatory
Article: HARM REDUCTION JOURNAL. 2023;20(1):72

Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden.

Lindqvist K; Thorin Z; Kåberg M
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2023;115:104021

Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.

Holmén E; Hammarberg A; Kåberg M; Storbjörk J
Article: SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY. 2023;18(1):24

Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.

Holmén E; Warnqvist A; Kåberg M
Article: QUALITY OF LIFE RESEARCH. 2023;32(1):197-207

Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden.

Kåberg M; Larsson S; Bergström J; Hammarberg A
Article: BMC PSYCHIATRY. 2022;22(1):770

Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?

Svensson J; Bergström J; Kåberg M; Becker P
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2022;107:103787

A rapid assessment of take-home naloxone provision during COVID-19 in Europe.

McDonald R; Eide D; Abel-Ollo K; Barnsdale L; Carter B; Clausen T; Day E; Fonseca F; Holmén E; Horsburgh K; Kelleher M; Kåberg M; Ladenhauf M; McAuley A; Metrebian N; Neale J; Parkin S; Ratcliffe K; Rintoul C; Smith J; Stifanoviciute V; Torrens M; Thiesen H; Strang J
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2022;7(5):396-415

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

Polaris Observatory HCV Collaborators
Article: EUROSURVEILLANCE. 2021;26(49):2002093

Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?

Wiessing L; Kalamara E; Stone J; Altan P; Van Baelen L; Fotiou A; Garcia D; Goulao J; Guarita B; Hope V; Jauffret-Roustide M; Jurgelaitienė L; Kåberg M; Kamarulzaman A; Lemsalu L; Kivite-Urtane A; Kolarić B; Montanari L; Rosińska M; Sava L; Horváth I; Seyler T; Sypsa V; Tarján A; Yiasemi I; Zimmermann R; Ferri M; Dolan K; Uusküla A; Vickerman P
Article: LIVER INTERNATIONAL. 2021;41(9):2024-2031

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19.

Blach S; Blomé M; Duberg A-S; Jerkeman A; Kåberg M; Klasa P-E; Lagging M; Razavi-Shearer D; Razavi H; Aleman S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(7):855-861

Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.

Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
Article: HARM REDUCTION JOURNAL. 2021;18(1):52

Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.

Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
Article: INTERNATIONAL JOURNAL OF DRUG POLICY. 2021;90:103059

A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden.

Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM
Article: PLOS ONE. 2021;16(6):e0253710

Mortality among amphetamine users with hepatitis C virus infection: A nationwide study.

Gahrton C; Håkansson A; Kåberg M; Jerkeman A; Häbel H; Dalgard O; Duberg A-S; Aleman S
Article: HARM REDUCTION JOURNAL. 2020;17(1):84

A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs.

Värmå Falk M; Strömdahl S; Ekström AM; Kåberg M; Karlsson N; Dahlborn H; Hammarberg A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(5):574-580

High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder.

Kåberg M; Larsson SB; Jerkeman A; Nystedt A; Duberg A-S; Kövamees J; Ydreborg M; Aleman S; Büsch K; Alanko Blomé M; Weiland O; Söderholm J
Article: INFECTIOUS DISEASES. 2020;52(5):336-346

Significant decrease in injection risk behaviours among participants in a needle exchange programme.

Kåberg M; Karlsson N; Discacciati A; Widgren K; Weiland O; Ekström AM; Hammarberg A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(3):319-327

Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity.

Kåberg M; Edgren E; Hammarberg A; Weiland O
Article: JOURNAL OF VIRAL HEPATITIS. 2018;25(12):1452-1461

Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination.

Kåberg M; Navér G; Hammarberg A; Weiland O
Article: JOURNAL OF HEPATOLOGY. 2018;68(3):402-411

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe.

Fraser H; Martin NK; Brummer-Korvenkontio H; Carrieri P; Dalgard O; Dillon J; Goldberg D; Hutchinson S; Jauffret-Roustide M; Kåberg M; Matser AA; Matičič M; Midgard H; Mravcik V; Øvrehus A; Prins M; Reimer J; Robaeys G; Schulte B; van Santen DK; Zimmermann R; Vickerman P; Hickman M
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2018;3(2):125-133

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.

Marshall AD; Cunningham EB; Nielsen S; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Seguin-Devaux C; Flisiak R; Foster GR; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancorienė L; Jarcuska P; Kåberg M; Kostrikis LG; Makara M; Maimets M; Marinho RT; Matičič M; Norris S; Ólafsson S; Øvrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J; International Network on Hepatitis in Substance Us
Article: INFECTIOUS DISEASES. 2017;49(10):728-736

Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.

Kåberg M; Hammarberg A; Lidman C; Weiland O
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2017;2(5):325-336

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

European Union HCV Collaborators
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2015;50(2):233-244

The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.

Duberg A-S; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21 Suppl 1:34-59

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21 Suppl 1:60-89

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E
Article: JOURNAL OF VIRAL HEPATITIS. 2014;21 Suppl 1:5-33

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P; Berg T; Øvrehus ALH; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(9):679-684

Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.

Lidman C; Norden L; Kåberg M; Käll K; Franck J; Aleman S; Birk M
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(10):727-734

Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.

Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
Visa fler

Alla övriga publikationer

Review: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2024;9(4):366-382

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Global HCV and HIV Treatment Restrictions Group
Review: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(6):533-552

Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.

Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P; HIV and HCV Incidence Review Collaborative Group
Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S176-S177

Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade

Kaberg M; Klasa P-E; Nordin T
Review: LIVER INTERNATIONAL. 2020;40 Suppl 1:61-66

Hepatitis C elimination - Macro-elimination.

Kåberg M; Weiland O
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S354-S355

Treatment of hepatitis C at the Stockholm needle syringe program - treatment success, reinfection rates and challenges for HCV elimination

Kaberg M; Lang A-M
Thesis / dissertation: 2019

Hepatitis C in people who inject drugs in the Stockholm needle exchange program : incidence, spontaneous clearance and change in risk behaviour

Kåberg, Martin
Meeting abstract: JOURNAL OF HEPATOLOGY. 2019;70(1):E498

Hepatitis C virus related liver fibrosis in people who inject drugs at the Stockholm Needle Exchange evaluated with liver elasticy

Kaberg M; Edgren E; Hammarberg A; Weiland O
Conference publication: HEPATOLOGY. 2019;70:366A

ELEVATED RISK FOR LIVER RELATED MORTALITY IN CHRONIC HEPATITIS C PATIENTS BOTH WITH OR WITHOUT ILLICIT SUBSTANCE USE DISORDER: A NATION-WIDE REGISTER STUDY

Soderholm J; Larsson SB; Jerkeman A; Nystedt A; Duberg A-S; Kovamees J; Ydreborg M; Aleman S; Busch K; Blome MA; Weiland OR; Kaberg M
Editorial comment: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2018;3(11):731-732

HCV treatment for people with recent drug use: time for new measures of success?

Øvrehus A; Kåberg M
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S95-S96

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

Marshall AD; Nielsen S; Cunningham EB; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Flisiak R; Foster G; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancoriene L; Jarcuska P; Kaberg M; Makara M; Maimets M; Marinho R; Maticic M; Norris S; Olafsson S; Ovrehus A; Pawlotsky J-M; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J
Conference publication: HEPATOLOGY. 2014;60:1047A

The impact of different strategies to reduce the burden of chronic hepatitis C infection, using new direct acting antivirals in Sweden

Duberg A-S; Blach S; Falconer K; Kaberg M; Razavi H; Aleman S

Forskningsbidrag

Risks of injection drug use in a Swedish context: Prevention of harms in practice according to users, treatment staff, and societal actors

Swedish Research Council for Health Working Life and Welfare

1 November 2021 - 31 October 2024
Preventive interventions for reducing mortality and morbidity among people who inject drugs – effects and experiences of Take-home naloxone within a needle exchange program

Swedish Research Council for Health Working Life and Welfare

1 November 2021 - 31 October 2024

Anställningar

Anknuten till Forskning, Global folkhälsa, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2019
Läkarexamen, Karolinska Institutet, 2002

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI